Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1991 Jul;32(1):127-9.
doi: 10.1111/j.1365-2125.1991.tb05625.x.

Reduction of LDL cholesterol by pravastatin does not influence platelet activation in patients with mild hypercholesterolaemia at risk of coronary heart disease

S E Barrow  1 , P D Stratton, N Benjamin, T Brassfield, J M Ritter
Affiliations
Clinical Trial

Reduction of LDL cholesterol by pravastatin does not influence platelet activation in patients with mild hypercholesterolaemia at risk of coronary heart disease

S E Barrow et al. Br J Clin Pharmacol. 1991 Jul.

Abstract

The effect of pravastatin on low density lipoprotein (LDL) cholesterol and platelet activation was studied in 16 patients with mild hypercholesterolaemia who had two or more additional cardiovascular risk factors. Patients were treated with either pravastatin (20-40 mg day-1) or placebo for 1 year. Plasma LDL and urinary excretion of 2,3-dinor-thromboxane B2 (an index of platelet activation in vivo) were determined at 0, 3, 6 and 12 months. There was a significant reduction in LDL at 6 and 12 months (2P less than 0.05) but this was not associated with any significant change in thromboxane metabolite excretion.

PubMed Disclaimer

References

    1. Thromb Res. 1987 Sep 15;47(6):647-56 - PubMed
    1. Eicosanoids. 1989;2(1):39-45 - PubMed
    1. Atherosclerosis. 1989 Sep;79(1):79-83 - PubMed
    1. Am J Med. 1986 Aug 25;81(2B):23-9 - PubMed
    1. Eur J Clin Invest. 1988 Jun;18(3):256-60 - PubMed

Publication types